Analyst Research: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

6.68USD
17 May 2013
Price Change (% chg)

$-0.51 (-7.09%)
Prev Close
$7.19
Open
$7.26
Day's High
$7.26
Day's Low
$6.50
Volume
337,468
Avg. Vol
304,068
52-wk High
$7.30
52-wk Low
$2.27

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Wright Investors Service Comprehensive Report for AcelRx Pharmaceuticals Inc 17 May 2013 Wright Reports 39 449.00
ACELRX PHARMACEUTICALS INC (ACRX) 12-months forecast 17 May 2013 Pechala's Reports 1 15.00
Thomson Reuters Stock Report - ACELRX PHARMACEUTICALS INC (ACRX-O) 17 May 2013 Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for ACRX 15 May 2013 ValuEngine, Inc. 11 127.00
AcelRx Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 10 May 2013 Reuters Investment Profile 12 20.00
ACELRX PHARMACT (ACRX) Zacks Company Snapshot 7 May 2013 Zacks Investment Research Inc. 1 12.00
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial Analysis Review 7 May 2013 GlobalData 35 125.00
TheStreet.com Ratings Stock Report For: ACELRX PHARMACEUTICALS INC 4 May 2013 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: ACELRX PHARMACEUTICALS INC 27 Apr 2013 TheStreet.com Ratings 5 10.00
 

People

Name Age Since Current Position

Adrian Adams

 62 2013 Independent Chairman of the Board

Richard King

 48 2010 President, Chief Executive Officer, Director

James Welch

 55 2010 Chief Financial Officer

Pamela Palmer

 50 2005 Chief Medical Officer, Director

Badri Dasu

 49 2007 Chief Engineering Officer
» More People

AcelRx Pharmaceuticals Inc News

Search Stocks